- Home
- AI vs VCYT Comparison
AI vs VCYT Comparison
Compare AI & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AI
- VCYT
- Stock Information
- Founded
- AI 2009
- VCYT 2006
- Country
- AI United States
- VCYT United States
- Employees
- AI N/A
- VCYT N/A
- Industry
- AI Computer Software: Prepackaged Software
- VCYT Medical Specialities
- Sector
- AI Technology
- VCYT Health Care
- Exchange
- AI Nasdaq
- VCYT Nasdaq
- Market Cap
- AI 2.3B
- VCYT 2.4B
- IPO Year
- AI 2020
- VCYT 2013
- Fundamental
- Price
- AI $15.62
- VCYT $32.43
- Analyst Decision
- AI Hold
- VCYT Buy
- Analyst Count
- AI 15
- VCYT 9
- Target Price
- AI $25.38
- VCYT $39.89
- AVG Volume (30 Days)
- AI 12.8M
- VCYT 1.3M
- Earning Date
- AI 09-03-2025
- VCYT 11-05-2025
- Dividend Yield
- AI N/A
- VCYT N/A
- EPS Growth
- AI N/A
- VCYT N/A
- EPS
- AI N/A
- VCYT 0.34
- Revenue
- AI $372,104,000.00
- VCYT $479,129,000.00
- Revenue This Year
- AI $13.06
- VCYT $14.19
- Revenue Next Year
- AI $15.85
- VCYT $9.68
- P/E Ratio
- AI N/A
- VCYT $96.53
- Revenue Growth
- AI 14.34
- VCYT 19.91
- 52 Week Low
- AI $14.70
- VCYT $22.61
- 52 Week High
- AI $45.08
- VCYT $47.32
- Technical
- Relative Strength Index (RSI)
- AI 28.01
- VCYT 68.26
- Support Level
- AI $14.80
- VCYT $29.38
- Resistance Level
- AI $17.54
- VCYT $30.69
- Average True Range (ATR)
- AI 0.71
- VCYT 1.11
- MACD
- AI 0.08
- VCYT 0.15
- Stochastic Oscillator
- AI 22.06
- VCYT 93.72
About AI C3.ai Inc.
C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Platform, which is an end-to-end application development and runtime environment for designing, developing, and deploying AI applications: C3 AI Applications, which is a portfolio of pre-built, extensible, industry-specific, and application-specific Enterprise AI applications: and C3 Generative AI, which combines the utility of large language models. Geographically the company derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and the Rest of the World.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.